对帕金森病和其遗传贡献者的认知表现的评估工具
Ling-Xiao Cao1,2, Wee Lee Kong3, Piu Chan4
1China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Frontiers in neurology
|July 11, 2024
概括
符号数字模式测试 (SDMT) 是评估帕金森病 (PD) 认知衰退的最佳方法. 遗传因素也显著影响PD患者的认知障碍和进展.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 认知科学 认知科学
背景情况:
- 影响帕金森病 (PD) 运动进展的遗传因素已知,但它们对认知功能的影响仍然不清楚.
- 在PD中,认知表现使用各种尺度进行评估,但对于选择最佳工具还没有明确的指南.
- 了解PD的认知衰退对于患者管理和治疗发展至关重要.
研究的目的:
- 确定最有效的认知查工具,用于检测帕金森病 (PD) 早期认知障碍.
- 评估不同认知评估的纵向性能,以追踪PD患者随时间推移的认知衰退.
- 研究遗传因素与PD患者认知能力下降的速度之间的关联.
主要方法:
- 利用了来自帕金森病进展标记计划 (PPMI) 的数据,包括认知评估和遗传信息.
- 使用五种工具评估认知表现:符号数字模式测试 (SDMT),蒙特利尔认知评估和其他工具,长达5年的时间.
- 采用接收器操作特征 (ROC) 分析,ANOVA和后勤回归来确定最佳的认知工具和与认知衰退的遗传关联.
主要成果:
- 符号数字模式测试 (SDMT) 在初始识别轻度认知障碍方面表现出卓越的表现 (AUC=0.763).
- SDMT是唯一一个在5年观察期间始终反映认知衰退的认知工具.
- 多遗传因素,特别是*IP6K2*rs12497850和*FGF20*rs591323,与早期认知障碍和PD更快的认知衰退有显著联系.
结论:
- 符号数字模式测试 (SDMT) 被推作为帕金森病 (PD) 认知评估的首选工具.
- 遗传因素在PD认知功能障碍的发展和进展中起着协同作用.
- 对遗传影响的进一步研究可以帮助预测和管理PD的认知衰退.
更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.8K
10:32Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
55.1K
相关概念视频
Parkinson's Disease: Overview
522
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
522
Parkinson's Disease: Treatment
251
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
251
Alzheimer's Disease: Overview
461
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
461
